INTRODUCTION
Oestrogen exerts multiple physiological and pathological effects. On the one hand, it is essential to development and maintenance of reproductive organs ; on the other, it may sustain growth of tumours that arise from these tissues [1] . In addition, oestrogen contributes to regulation of the structure of the bone, and to functioning of the cardiovascular and central nervous system [1] . These actions are mediated through activation of various receptors, which include the classical nuclear receptors [1] and receptors at the plasma membrane, whose molecular identity has not yet been fully elucidated [2] [3] [4] [5] . Heterogeneity of receptors may explain why oestrogen, together with the well-known ability to initiate gene transcription at the oestrogen responsive elements (ERE), often triggers complex patterns of intracellular signals switched on from the first minutes after hormone administration. These non-genomic actions include activation of adenylate cyclase and phospholipase Cβ, mobilization of intracellular calcium, regulation of ion channels, activation of both the phosphatidylinositol 3h-kinase (PI3K)\protein kinase B (Akt) pathway and the extracellular signal-regulated kinases (ERK 1\2) [6] . Also insulin receptor substrate 1 (IRS-1), a docking Abbreviations used : Ab, antibody ; 8 Br, 8-bromo ; cGMP, cyclic GMP ; DETA-NO, (Z)-1-[2-(2-aminoethyl)-N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate ; DMEM, Dulbecco modified Eagle's medium ; E 2 , 17β-oestradiol ; ECL2, enhanced chemiluminescence ; ERE, oestrogen-responsive element ; ERK 1/2, p42/44 extracellular signal-regulated kinases ; IGF-1 and IGF-1R, insulin-like growth factor 1 and its receptor ; IRS-1, insulin receptor substrate 1 ; mAb, monoclonal antibody ; MAP kinase, mitogen-activated protein kinase ; MEK, MAP kinase/ERK kinase ; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide ; NO, nitric oxide ; NOS, NO synthase ; ODQ, H- [1, 2, 4] oxadiazolo [4,3-α] quinoxalin-1-one ; PI3K, phosphatidylinositol 3h-kinase. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (e-mail clementi.emilio!hsr.it).
through generation of cyclic GMP and activation of the cGMPdependent protein kinase I, initiated in the first minutes after administration of oestrogen. The consequences, however, were long lasting, as modulation of Akt and ERK 1\2 activities by NO was responsible for inhibition of E # -triggered cell growth and regulation of oestrogen responsive-element dependent gene transcription. Generation of NO is stimulated by both E # and growth factors known to contribute to the complex network of intracellular events regulating the biological actions of oestrogen. It is conceivable, therefore, that modulation by NO of E # early signalling, here described for the first time, has broad significance in regulating cellular responses to the hormone.
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protein which acts as a major substrate for growth factors, may be involved in oestrogen signalling [7] [8] [9] [10] [11] . This, however, has been reported to occur only in the presence of growth factors, or after long exposure to oestrogen, conditions in which IRS-1 contributes to the cross-talk between the steroid and insulin or insulin-like growth factor-1 (IGF-1) [8] [9] [10] [11] .
Increasing evidence indicates that an effector molecule crucial for oestrogen signalling is the short-lived messenger nitric oxide (NO) . NO participates in cardio-protective and antiatherosclerotic effects of oestrogen, as well as in the effects of the steroid in the central nervous system and bone metabolism. Until now these effects have been mostly attributed to direct actions of NO on target tissues, including its well-known vasodilating and anti-atherogenic properties [12] . However, the observation that oestrogen not only increases expression of NO synthesizing enzymes (NOS) [13] , but also triggers direct activation of endothelial NOS in the first minutes after its addition to cells [3, 4, [14] [15] [16] , opens the possibility that part of the NO effects on oestrogen biological actions are also mediated through regulation of the signal transduction cascades initiated by the hormone. So far, this possibility has never been investigated.
In the present work we have used an established model for studies on oestrogen signalling, the human breast cancer cell line MCF-7, exposed to 17β-oestradiol (E # ) and the NO donor (
Our results show that NO renders E # competent to trigger rapid tyrosine phosphorylation, and thus activation, of IRS-1. This initiates a complex chain of events that include recruitment of PI3K, persistent activation of Akt and ensuing inhibition of E # -triggered ERKs activation. These effects of NO on E # signalling were found to be mediated through activation of guanylate cyclase, generation of cyclic GMP (cGMP) and ensuing stimulation of the cGMP-dependent protein kinase I (G kinase), and to have long-lasting consequences on cellular responses to the steroid.
EXPERIMENTAL Materials
The following reagents were purchased as indicated : H- [ 
Cell cultures and preparation
MCF-7 cells, provided by Dr Eva Surmacz (Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA, U.S.A.), were routinely cultured in Dulbecco's modified Eagle's medium (DMEM)\F12 (1 : 1) supplemented with 5 % calf serum in a 5 %-CO # humidified atmosphere. These cells were chosen not only because they are an established model for E # signalling, but also because they are devoid of any detectable NOS, as demonstrated by both Western blotting ( Figure 1 ) and measurements of NOS activity, carried out as described previously [17] . At the time of experiments, subconfluent cell cultures were detached by trypsinization, cultured in growth medium for 24 h and then for an additional 24 h in DMEM without Phenol Red and serum. Experiments were carried out using 70 % confluent cells in DMEM without Phenol Red and serum. All incubations with the various compounds were for 15 min prior to addition of E # (time 0).
Immunoprecipitation and Western blotting
Cells, incubated with the various compounds as detailed in the results, were treated with E # and washed twice, at the indicated time points, with a cold buffer [150 mM NaCl, 1.5 mM MgCl # , 
Figure 1 MCF-7 cells do not express NOS isoforms

Cell-proliferation assays
For the colorimetric assay with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) [20] , MCF-7 cells were plated in 24-multiwell plates at the concentration of 4i10$ cells\ well in growth medium. After 2 days the medium was replaced with DMEM (without Phenol Red and serum) for 24 h. Cells were then incubated with various compounds, as detailed in the Results section, and treated with E # . At the indicated time points (days 1-3) cells were washed, 0.5 ml of MTT stock solution (2.4 mM in DMEM without Phenol Red, filtered) was added, and the plates were incubated for 1 h at 37 mC. At the end of the incubation the non-transformed MTT was carefully removed and the dye crystals solubilized in 1 ml of 2-propanol. Absorbances were read immediately in a UVKON 941 spectrophotometer using a test wavelength of 570 nm and a reference wavelength of 690 nm.
Statistical analysis
The results are expressed as meanspstandard error of the mean ; n represents the number of different experiments, which were run in triplicate. Western-blotting data are representative of 3 to 4 experiments, as specified in each Figure legend. Statistical analysis was performed by the Student's t test for unpaired data (two-tail). The symbols *, ** and *** or j, jj, jjj in Table 1 and Figure 8 refer to statistical probabilities (P) of 0.05, 0.01 and 0.001, respectively, as detailed in the legend to Figure 8 . A value of P less than 0.05 was considered to be statistically significant.
RESULTS
The MCF-7 cells used in our experiments are devoid of any detectable NOS, as detected by Western blotting with specific Abs recognizing specifically the endothelial, the neuronal or the inducible NOS ( Figure 1 ). In addition, they display no NOS activity, which was assessed by measuring arginine to citrulline conversion as described previously [17] (results not shown). Absence of endogenous NO generation makes these cells a clean system to study the effects of NO. Experiments were carried out using the NO donor DETA-NO which, at the concentration employed (100 µM), released NO at the constant concentration of 0.21p0.2 µM (n l 4), as measured by an NO electrode [21] . To investigate the effects of NO on E # -induced tyrosine phosphoryl- ation, sub-confluent MCF-7 cells were exposed to DETA-NO, E # (1 nM) and the oestrogen antagonist ICI 182,780 (100 nM), administered either alone or combined. Tyrosine phosphorylation was measured by Western blotting at different time points after stimulation, as indicated in Figure 2 . The effect of E # was relatively small and transient, as shown previously in these cells [22] . DETA-NO did not have any effect when administered alone. Combination of E # with DETA-NO, instead, resulted in markedly enhanced tyrosine phosphorylation staining which, in addition, became persistent throughout the time-window analysed (1 h). In the presence of ICI 182,780, tyrosine phosphorylation was observed with E # neither when administered alone nor when combined with DETA-NO ( Figure 2 , and results not shown).
The pattern of tyrosine phosphorylation observed with E # and NO included also proteins in the 150-190 kDa range, among which is IRS-1. To verify the involvement of the latter, cells, treated as above, were lysed and IRS-1 immunoprecipitated with an anti-IRS-1 specific Ab. Tyrosine phosphorylation of the precipitates was analysed by Western blotting. As shown in Figure 3 , E # and DETA-NO had no effect when given alone. By contrast, when administered together, they induced tyrosine phosphorylation of IRS-1, which was already present after 5 min of treatment and maintained throughout the period analysed. This tyrosine phosphorylation was not observed in the presence of ICI 182,780.
NO may exert its effect either through activation of guanylate cyclase, generation of cGMP and activation of G kinase or through alternative pathways [23] . To establish whether NO was acting in a cGMP-dependent manner, experiments were carried out in the presence of the membrane-permeant cGMP analogue, 8-bromo (8 Br)-cGMP (1 mM), the guanylate cyclase inhibitor, ODQ (1 µM), or the selective G kinase inhibitor KT5823 (5 µM) [24] . 8 Br-cGMP mimicked the effect of DETA-NO, as it was ineffective when given alone, while inducing tyrosine phosphorylation of IRS-1 in the presence of E # with kinetics similar to those of the NO donor. Consistent with this observation, coincubation in the presence of ODQ abrogated the effect of DETA-NO. Co-incubation in the presence of KT5823 also reversed the effect of DETA-NO (Figure 3 ). To establish whether the effects observed were due to actual changes in tyrosine phosphorylation of IRS-1 or secondary to changes in IRS-1 protein levels, all Western blots were stripped of the anti-tyrosine Ab and decorated with the anti-IRS-1 Ab. No changes in IRS-1 protein were observed in all cases (Figure 3 ). Taken together, these results indicate that NO and E # synergize to induce tyrosine phosphoryl- ation of IRS-1 and that the effect of the gaseous messenger is dependent on generation of cGMP and activation of G kinase. IRS-1 is a major substrate for IGF-1R, and its tyrosine phosphorylation contributes significantly to the cross-talk between the signalling pathways activated by this receptor and E # . In particular, IRS-1 tyrosine phosphorylation, induced by activation of IGF-1R with either IGF-1 or insulin, appears to be enhanced in the presence of E # [9] [10] [11] . We investigated, therefore, whether synergism between NO and E # in triggering tyrosine phosphorylation of IRS-1 was due to activation of IGF-1R. To this end, cells were exposed to E # , DETA-NO, or the two together, and IGF-1R tyrosine phosphorylation analysed after receptor immunoprecipitation with an anti-IGF-1R specific Ab. At variance with IGF-1, which induced marked IGF-1R phosphorylation after 10 min treatment, E # was ineffective both when administered alone (as already shown in MCF-7 cells, see [9, 10] and when combined with DETA-NO (Figure 4) . The amount of IGF-1R protein precipitated by the anti-IGF-1R Ab, however, was the same in all conditions (Figure 4) . These results indicate that IGF-1R is unlikely to play a role in IRS-1 activation by E # in the presence of NO.
IRS-1 acts as an adapter to various downstream effector molecules, among which is PI3K, whose recruitment and activation is increased following IRS-1 tyrosine phosphorylation [25] [26] [27] . Recruitment of the PI3K p85 regulatory subunit to IRS-1 was therefore analysed. After administration of E # and NO, either alone or combined, IRS-1 was immunoprecipitated and the amount of co-precipitated p85 detected by Western blotting. Treatment with either DETA-NO or E # alone revealed no p85 co-precipitation. By contrast, this was clearly observed when the two stimuli were applied together ( Figure 5 ). The amount of IRS-1 protein immunoprecipitated was the same in all conditions ( Figure 5 ).
To investigate whether recruitment of p85 to IRS-1 induced by the combination of NO and E # resulted in stimulation of PI3K activity we examined activation of a well-known downstream effector of this enzyme, i.e. Akt, using an Ab recognizing selectively the phosphorylated, active form of the protein ( Figure 6 ). E # induced activation of Akt which, however, was transient (up Table 1 .The experiments shown are representative of four.
to 15 min). DETA-NO did not have an effect per se, but enhanced Akt activation by E # ; significantly, both in intensity and duration. This effect was abolished when cells were incubated with either ICI 182,780 or a PI3K inhibitor, namely wortmannin (20 nM) or LY 294002 (10 µM), indicating the involvement of the oestrogen receptor and PI3K ( Figure 6 and results not shown). The effect of DETA-NO was mimicked by 8 Br-cGMP and reversed by either ODQ or KT5823, demonstrating also that Akt activation by NO in the presence of E # depends on cGMP generation and G kinase activation. When Western blots, used to reveal active Akt, were decorated with an Ab recognizing both the active and inactive protein, no difference in total Akt levels was detected in all condition tested ( Figure 6 ). Thus, NO appears capable of enhancing Akt activation by E # through the IRS-1\ PI3K pathway, turned on in a cGMP\G kinase-dependent fashion.
An early signalling event triggered independently by both E # and NO, the latter acting through the cGMP\G kinase pathway, is activation of ERK 1\2 [28] [29] [30] [31] [32] . The effects of E # and DETA-NO on ERK 1\2 activation were therefore investigated by using Abs recognising specifically either total ERK 1\2 or its phosphorylated, active form. Both E # and DETA-NO, when administered alone, induced activation of ERK 1\2, which was persistent throughout the time window analysed ( Figure 7 and Table 1 ). ERK 1\2 activation was inhibited in both cases by coadministration of the MEK (MAP kinase\ERK kinase) inhibitor PD 98059 (30 µM), indicating involvement of this enzyme in ERK 1\2 activation. The effect of E # was prevented by ICI 182,780. When we examined the effects of the combined administration of E # and NO we found that they were not additive but gave rise to complete abrogation of ERK 1\2 activation. Both the stimulation of ERK 1\2 by NO and their inhibition in the presence of E # were found to be dependent on generation of cGMP and activation of G kinase, as these effects of (Figure 7 , Table 1 and results not shown).
The mechanism of inhibition of ERK 1\2 in the presence of NO\cGMP and E # was next investigated. ERK 1\2 are inhibited by stimulation of the PI3K\Akt pathway [33] . Since this pathway is activated in the presence of NO\cGMP and E # (Figures 3 and  4) , we assessed its involvement in inhibition of ERK 1\2. When cells were exposed to E # together with either DETA-NO or 8 Br-cGMP, and in the presence of wortmannin or LY 294002, ERK 1\2 activation was restored, with enzyme activation greater than that observed with E # , DETA-NO or 8 Br-cGMP alone ( Figure 7 , Table 1 and results not shown). These results suggest strongly that the inhibition of ERK 1\2 in the presence of NO\ cGMP and E # is due to concomitant PI3K\Akt activation. PI3K\Akt and ERK 1\2 have been shown to enhance the E # -induced stimulation of ERE-containing genes [34, 35] . To evaluate whether the regulation of PI3K\Akt and ERK 1\2 pathways described above influences the ability of E # to activate EREdependent transcription, cell were transiently transfected with a luciferase reporter gene under the control of a ERE element (EREtkLuc, described in [19] ). Exposure to E # for 8 h induced EREtkLuc expression, with ensuing luciferase expression, which was abolished by co-incubation with ICI 182,780 ( Figure 8A ). Treatment with PD 98059, wortmannin, or LY 294002 resulted in inhibition of E # effects on EREtkLuc, that was more pronounced when PD 98059 and either PI3K inhibitor were both present ( Figure 8A and results not shown) .
We then examined the effects of DETA-NO and 8 Br-cGMP. Results were similar with both compounds, therefore only those obtained with 8 Br-cGMP are described in detail ( Figure 8A ). The cyclic nucleotide had no effects on EREtkLuc. Likewise, it did not modify EREtkLuc response to E # administration when co-administered with the steroid. As demonstrated above, however, E # signalling is profoundly modified by cGMP, with PI3K\Akt greatly stimulated and ERK 1\2 inhibited. We investigated the role of these changed kinase activities. In the presence of wortmannin or LY 294002, luciferase expression induced by co-administration of 8 Br-cGMP with E # was not modified, presumably because of the concomitant greater activation of ERK 1\2 observed when PI3K inhibitors are administered prior to 8 Br-cGMP and E # (see above). Consistently, addition of PD 98059 together with either wortmannin or LY 294002 inhibited to a great extent luciferase expression induced by co-administration of 8 Br-cGMP with E # , with values similar to those observed with E # in the presence of PD 98059 and either PI3K inhibitor ( Figure 8A and results not shown). This suggests that PI3K\Akt activation and concomitant ERK 1\2 inhibition by 8 Br-cGMP compensate each other, resulting in no changes in E # -stimulated ERE-dependent transcription. Activation of ERK 1\2 and gene transcription are relevant to mitogenic effects of E # [35] [36] [37] . We therefore evaluated whether the NO-induced, cGMP-dependent regulation of E # signalling influences the mitogenic properties of the steroid. Since NO also acts on growth independently of cGMP ( [24] and references therein), we analysed specifically the effect of the cyclic nucleotide. Cell proliferation was measured using an established technique, i.e. conversion of MTT into its derivative, formazan [20] .
Administration of E # induced cell proliferation, which was completely inhibited by ICI 182,780. Blockade of ERK 1\2 activation with PD 98059 resulted in reduced E # -dependent cell proliferation, whereas wortmannin or LY 294002 modified the effect of neither E # nor E # plus PD 98059 ( Figure 8B , and results not shown). These results are consistent with the involvement of ERK 1\2 in E # -induced cell proliferation already described in these cells [37] . 8 Br-cGMP itself induced a small, yet significant increase in cell proliferation ( Figure 8B ). The effect of the cyclic nucleotide, however, was not additive with that of E # . On the contrary, when E # and 8 Br-cGMP were administered together, cell proliferation was inhibited to a large extent. This inhibition was likely due to PI3K\Akt-dependent inhibition of ERK 1\2, as it failed to appear when 8 Br-cGMP and E # were administered in the presence of wortmannin or LY 294002 ( Figure 8B and results not shown). Consistent with this, administration of E # and 8 BrcGMP together with PD 98059 did not result in further inhibition ( Figure 8B ). These results indicate that regulation by NO\cGMP of E # signalling pathways results in modulation of one of the important functions of the steroid, i.e. cell proliferation.
DISCUSSION
A fascinating aspect of E # is its ability to trigger complex patterns of cell responses that contribute to co-ordinate growth, development and differentiation of organs as diverse as those forming the reproductive systems of both females and males, mammary glands, bone, cardiovascular and central nervous systems. The discovery that E # interacts with distinct membrane and nuclear receptors to trigger both rapid signal transduction Regulation of oestrogen signalling by nitric oxide , were treated with or without E 2 for 1-3 days, after which the MTT assay was carried out as described in the Experimental section. Absorbances were measured using a test wavelength of 570 nm and a reference wavelength of 690 nm. In both panels, statistical probability versus untreated controls is indicated by the asterisks, that versus cells treated with E 2 alone with crosses, and both calculated as described in the Experimental section (n l 6).
events and more prolonged regulation of gene transcription, and that these signals integrate and partially overlap with those of growth factors and cytokines, provides a molecular explanation to such complex effects of the steroid [1, 6] . The efficiency of E # signalling, however, together with the pathological consequences arising from its disregulation (tumours, for example) suggest that its signal transduction pathways are exquisitely co-ordinated. Our results show that NO contributes substantially to such coordination, in analogy with similar actions by NO on signalling pathways activated by other receptor agonists [17, 38] .
Indeed, NO modifies profoundly the whole pattern of early signalling events triggered by E # . A first effect is that of increasing E # ability of phosphorylating proteins on tyrosine. In particular, in the presence of NO, E # becomes competent to induce an early (min) phosphorylation, and thus activation, of IRS-1. We have investigated possible mechanisms underlying such effect of NO. Previous reports indicated that tyrosine phosphorylation of IRS-1 in the presence of E # occurs as a consequence of synergistic action between the hormone and agonists of IGF-1R [9] [10] [11] . Our results, however, indicate that the involvement of this receptor in mediating the effects of NO is unlikely, because co-administration of E # and NO did not result in increased IGF-1R activation. In contrast, we found that the effect of NO is mediated through generation of cGMP and activation of G kinase, a member of the serine\threonine family of protein kinases known to mediate several physiological effects of NO [23] . Phosphorylation of IRS-1 by other members of this family of kinases, namely protein kinase Cs, Akt [possibly via activation of mTOR (mammalian target of rapamycin)], stress and mitogen-activated protein kinases, was shown in various cell systems. This resulted, however, in impairment of IRS-1 function [39] [40] [41] [42] . The ability of G kinase to activate, rather than inhibit, IRS-1 function might be due to direct phosphorylation on specific sites different from those affected by these other kinases, or mediated through phosphorylation of intermediate, as yet unidentified, molecules.
Until now involvement of IRS-1 in signalling by E # had been recognized to be limited to specific conditions, because it appeared to require either long-term exposure to the steroid, with increased expression of the adapter, or the combined administration of E # with insulin and IGF-1 [8] [9] [10] [11] . The finding that NO enables activation of IRS-1 by E # independently of IGF-1R activation suggests that the role for the adapter in oestrogen signalling is broader than previously recognized. In particular, IRS-1 might be ordinarily involved in transducing E # signals in cells endowed with the E # -activatable, endothelial NOS. This is of biological relevance in view of our findings that IRS-1, when activated, is central to regulation of the signalling pathways activated by E # . The first important consequence of IRS-1 involvement in E # signalling is the recruitment of PI3K and the ensuing activation of Akt. A stimulation of Akt by E # due to direct interaction of PI3K with the oestrogen receptor, i.e. without involvement of IRS-1, has already been described [4, 15, 16] . We found, however, that the two modes of Akt activation, i.e. IRS-1-dependent and independent, differ profoundly in terms of kinetics. IRS-1-independent activation is small and transient (see also [4] and [15] ), whereas that induced by recruitment of IRS-1 through the NO\cGMP\ G kinase pathway is persistent and more conspicuous.
There are important implications of this persistent Akt activation. Akt is a messenger through which E # activates endothelial NOS to generate NO [4, 16] . In cells endowed with this enzyme NO might therefore act in a Akt-centred, feed-forward loop aimed at amplifying the initial steps of E # signalling. In addition, Akt has been recently shown to be among the signals through which various growth factors trigger phosphorylation of the activation function-1 domain of oestrogen receptor α, thereby enhancing receptor activity [43] . This, together with the observation that growth factors also generate NO\cGMP [38] suggests that the gaseous messenger does contribute substantially to the cross-talk between the signalling pathways activated by E # and growth factors. This might be of relevance in view of the regulatory role that such cross-talk plays in modulating biological functions of tissues target of oestrogen [1] .
Change in ERK 1\2 function is another important consequence of the E # \NO-induced recruitment to E # signalling of the IRS-1-PI3K\Akt pathway. Activation of ERK 1\2, which is marked when either E # or NO\cGMP are administered independently ( [28] [29] [30] [31] [32] , and this paper), was inhibited when they were combined. This was consequent to activation of PI3K, because inhibition of PI3K with either wortmannin or LY 294002 reverted this effect, enabling additive activation of ERK 1\2 by the steroid and the gaseous messenger. Akt stimulation by PI3K is known to impair ERK 1\2 activation through inhibition of the Raf proteins [33] . Since both E # and NO (via G kinase) activate ERK 1\2 through the Raf\MEK pathway ( [28, 31, 32] and this paper), it is conceivable that Akt-dependent inhibition of Raf is the mechanism underlying the switch-off of ERK 1\2 stimulation observed in the presence of E # and NO. Activation of ERK 1\2 is relevant to mitogenic effects of E # [37] , which, however, involve not only physiological stimulation of growth but also its tumourigenic development, especially in reproductive organs [1] . Activation of the NO\cGMP pathway by E # , and ensuing inhibition of ERK 1\2, might therefore contribute to regulate E # signalling and inhibit generation of abnormal mitogenic signals. This hypothesis is substantiated by the observation that MCF-7 cell growth triggered by E # was inhibited in the presence of cGMP. This inhibition was due to the cGMP-dependent blockade of ERK 1\2, mediated via activation of the PI3K\Akt pathway.
Akt and ERK 1\2 phosphorylate oestrogen receptor α, thereby enhancing the ability of E # to promote transcription of EREcontaining genes [34, 35, 44] . Consistent with these observations we found that inhibition of either kinase resulted in reduced activation of ERE by E # , measured using the EREtkLuc reporter gene. The IRS-1-dependent changes in PI3K\Akt and ERK 1\2 activities induced by the concomitant administration of NO\ cGMP together with E #, instead, did not modify significantly the effects of E # on ERE, most likely because of the balance between inhibition of ERK 1\2 and stimulation of Akt. Thus, while inhibiting E # -dependent cell growth, NO\cGMP appear to maintain the ability of the steroid to stimulate gene transcription. It must be noted, however, that gene transcription by E # involves interaction of oestrogen receptors with a vast array of co-activators and co-repressors [45] . Direct effects of NO\cGMP on these proteins, with changes in their ability to interact with oestrogen receptors or target sequences, cannot be excluded by our experiments. In addition, NO\cGMP activates the AP-1 transcription complex, which may contribute to E # -dependent gene transcription [24, 46, 47] . Thus, the combination of E # with NO\cGMP might also lead to changes in expression of specific genes. E # sustains differentiation of target tissues, especially reproductive organs, to which NO also contributes [1, 48] . Cell growth and gene expression are relevant to this function of the steroid. In view of this, the dual action by NO on E # signalling described here might have evolved to contribute to the developmental actions by E # . Activation of IRS-1 by the combined action of E # and the NOstimulated cGMP\G kinase pathway may result in downstream signalling events additional to those reported here. IRS-1 has over 20 potential tyrosine-phosphorylation sites, which serve as binding sites to a variety of SH2 domain-containing messenger molecules [7] . Whether the pattern of tyrosine phosphorylation induced by co-stimulation with E # and NO leads to recruitment of PI3K\Akt only or also of any of these other effectors remains to be investigated.
In conclusion, our results show that NO, through generation of cGMP and activation of G kinase, modifies profoundly E # early signalling and contributes to regulate long-term actions of the steroid. Generation of NO, formation of cGMP and activation of G kinase is triggered in most cells by a variety of receptors, including tyrosine kinase and G-protein-coupled receptors, as well as receptors for cytokines, in both physiological and pathological conditions [17, 23, 38] . It is conceivable, therefore, that the overall regulation of E # signalling by NO described here is a common pathway regulating oestrogen biological activity.
